Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis.

Gorelik E, Masarwa R, Perlman A, Rotshild V, Abbasi M, Muszkat M, Matok I.

Drug Saf. 2019 Apr;42(4):529-538. doi: 10.1007/s40264-018-0751-2.

PMID:
30368737
2.

Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.

Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I.

Am J Obstet Gynecol. 2019 Jan;220(1):57.e1-57.e13. doi: 10.1016/j.ajog.2018.08.030. Epub 2018 Aug 28. Review.

PMID:
30170040
3.
4.

Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.

Gorelik E, Masarwa R, Perlman A, Rotshild V, Muszkat M, Matok I.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00438-18. doi: 10.1128/AAC.00438-18. Print 2018 Jun.

5.

Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland.

Berkovitch M, Ashkenazi-Hoffnung L, Youngster I, Shaniv D, Dil-Nahlieli D, Gorelik E, Schäublin M, Stoller R, Karra N, Schwartzberg E.

Front Pharmacol. 2017 Nov 21;8:843. doi: 10.3389/fphar.2017.00843. eCollection 2017.

6.

Pharmacovigilance in Israel - tools, processes, and actions.

Schwartzberg E, Berkovitch M, Dil Nahlieli D, Nathan J, Gorelik E.

Isr J Health Policy Res. 2017 Aug 1;6(1):29. doi: 10.1186/s13584-017-0154-3.

7.

Breaking the semi-quinoid structure: spin-switching from strongly coupled singlet to polarized triplet state.

Ravat P, Teki Y, Ito Y, Gorelik E, Baumgarten M.

Chemistry. 2014 Sep 15;20(38):12041-5. doi: 10.1002/chem.201403338. Epub 2014 Jul 31.

PMID:
25081828
8.

Tetramethoxypyrene-based biradical donors with tunable physical and magnetic properties.

Ravat P, Ito Y, Gorelik E, Enkelmann V, Baumgarten M.

Org Lett. 2013 Sep 6;15(17):4280-3. doi: 10.1021/ol4015859. Epub 2013 Aug 23.

PMID:
23971416
9.

CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma.

Mandapathil M, Szczepanski M, Harasymczuk M, Ren J, Cheng D, Jackson EK, Gorelik E, Johnson J, Lang S, Whiteside TL.

Oncoimmunology. 2012 Aug 1;1(5):659-669.

10.

Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation.

Levina V, Su Y, Gorelik E.

Clin Dev Immunol. 2012;2012:173029. doi: 10.1155/2012/173029. Epub 2012 May 13.

11.

Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.

Su Y, Jackson EK, Gorelik E.

Cancer Immunol Immunother. 2011 Jan;60(1):111-22. doi: 10.1007/s00262-010-0924-z. Epub 2010 Oct 20.

12.

Néel transition of lattice fermions in a harmonic trap: a real-space dynamic mean-field study.

Gorelik EV, Titvinidze I, Hofstetter W, Snoek M, Blümer N.

Phys Rev Lett. 2010 Aug 6;105(6):065301. Epub 2010 Aug 3.

PMID:
20867987
13.

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.

Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT, Gorelik E, Lang S, Whiteside TL.

J Biol Chem. 2010 Sep 3;285(36):27571-80. doi: 10.1074/jbc.M110.127100. Epub 2010 Jun 17.

14.

[Autoimmune states correction for pathologic component (link) elimination that hinder physiologic osteogenesis].

Bolotanova MK, Orlov AA, Potemkin AV, Mamaev SV, Maevskiĭ EI, Serebriakova LE, Gorelik EI.

Stomatologiia (Mosk). 2010;89(1):30-2. Russian.

PMID:
20436406
15.

Development of a multimarker assay for early detection of ovarian cancer.

Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC Jr, Lokshin AE.

J Clin Oncol. 2010 May 1;28(13):2159-66. doi: 10.1200/JCO.2008.19.2484. Epub 2010 Apr 5.

16.

Lung cancer stem cells as a target for therapy.

Gorelik E, Lokshin A, Levina V.

Anticancer Agents Med Chem. 2010 Feb;10(2):164-71. Review.

PMID:
20184538
17.

Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents.

Feng R, Rios JA, Onishi T, Lokshin A, Gorelik E, Lentzsch S.

Leuk Res. 2010 Jul;34(7):917-24. doi: 10.1016/j.leukres.2009.12.002. Epub 2010 Feb 8.

PMID:
20116850
18.

Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.

Levina V, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E.

Cancer Res. 2010 Jan 1;70(1):338-46. doi: 10.1158/0008-5472.CAN-09-1102. Epub 2009 Dec 22.

19.

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.

Mandapathil M, Hilldorfer B, Szczepanski MJ, Czystowska M, Szajnik M, Ren J, Lang S, Jackson EK, Gorelik E, Whiteside TL.

J Biol Chem. 2010 Mar 5;285(10):7176-86. doi: 10.1074/jbc.M109.047423. Epub 2009 Oct 26.

20.

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.

Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Lenzner DE, Jackson EK, Gorelik E, Lang S, Johnson JT, Whiteside TL.

Clin Cancer Res. 2009 Oct 15;15(20):6348-57. doi: 10.1158/1078-0432.CCR-09-1143. Epub 2009 Oct 13.

21.

Biological significance of prolactin in gynecologic cancers.

Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE.

Cancer Res. 2009 Jun 15;69(12):5226-33. doi: 10.1158/0008-5472.CAN-08-4652. Epub 2009 Jun 2.

22.

Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.

Mandapathil M, Lang S, Gorelik E, Whiteside TL.

J Immunol Methods. 2009 Jul 31;346(1-2):55-63. doi: 10.1016/j.jim.2009.05.004. Epub 2009 May 18.

23.

Time-resolved EPR investigation of potential model systems for acrylate polymer main chain radicals based on esters of Kemp's tri-acid.

Lebedeva NV, Gorelik EV, Magnus-Aryitey D, Hill TE, Forbes MD.

J Phys Chem B. 2009 May 14;113(19):6623-9. doi: 10.1021/jp809610t.

PMID:
19374361
24.

Role of eotaxin-1 signaling in ovarian cancer.

Levina V, Nolen BM, Marrangoni AM, Cheng P, Marks JR, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE.

Clin Cancer Res. 2009 Apr 15;15(8):2647-56. doi: 10.1158/1078-0432.CCR-08-2024. Epub 2009 Apr 7.

25.

Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration.

Geuking MB, Weber J, Dewannieux M, Gorelik E, Heidmann T, Hengartner H, Zinkernagel RM, Hangartner L.

Science. 2009 Jan 16;323(5912):393-6. doi: 10.1126/science.1167375.

26.

A serum based analysis of ovarian epithelial tumorigenesis.

Nolen B, Marrangoni A, Velikokhatnaya L, Prosser D, Winans M, Gorelik E, Lokshin A.

Gynecol Oncol. 2009 Jan;112(1):47-54. doi: 10.1016/j.ygyno.2008.09.043. Epub 2008 Nov 12.

27.

Thermally induced magnetic anomalies in solvates of the bis(hexafluoroacetylacetonate)copper(II) complex with pyrazolyl-substituted nitronyl nitroxide.

Ovcharenko VI, Romanenko GV, Maryunina KY, Bogomyakov AS, Gorelik EV.

Inorg Chem. 2008 Oct 20;47(20):9537-52. doi: 10.1021/ic8011074. Epub 2008 Sep 10.

PMID:
18781735
28.

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.

Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE.

PLoS One. 2008 Aug 27;3(8):e3077. doi: 10.1371/journal.pone.0003077.

29.

Chemotherapeutic drugs and human tumor cells cytokine network.

Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E.

Int J Cancer. 2008 Nov 1;123(9):2031-40. doi: 10.1002/ijc.23732.

30.

Model systems for poly(acrylic acid) main-chain radicals based on the Kemp's triacid framework.

Lebedeva NV, Gorelik EV, Prowatzke AM, Forbes MD.

J Phys Chem B. 2008 Jun 26;112(25):7574-80. doi: 10.1021/jp712098j. Epub 2008 Jun 3.

PMID:
18517241
31.

Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression.

Su Y, Huang X, Raskovalova T, Zacharia L, Lokshin A, Jackson E, Gorelik E.

Cancer Immunol Immunother. 2008 Nov;57(11):1611-23. doi: 10.1007/s00262-008-0494-5. Epub 2008 Mar 8.

PMID:
18327580
32.

Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production.

Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE.

Exp Cell Res. 2008 Apr 15;314(7):1605-16. doi: 10.1016/j.yexcr.2007.12.027. Epub 2008 Jan 16.

33.

Ligand effects on the ferro- to antiferromagnetic exchange ratio in bis(o-semiquinonato)copper(II).

Ovcharenko VI, Gorelik EV, Fokin SV, Romanenko GV, Ikorskii VN, Krashilina AV, Cherkasov VK, Abakumov GA.

J Am Chem Soc. 2007 Aug 29;129(34):10512-21. Epub 2007 Aug 3.

PMID:
17676737
34.

Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.

Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, Lokshin A.

Gynecol Oncol. 2007 Oct;107(1):58-65. Epub 2007 Jul 19.

35.

Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.

Raskovalova T, Lokshin A, Huang X, Su Y, Mandic M, Zarour HM, Jackson EK, Gorelik E.

Cancer Res. 2007 Jun 15;67(12):5949-56.

36.

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE.

Clin Cancer Res. 2007 Apr 15;13(8):2422-8.

37.
38.

Multianalyte profiling of serum cytokines for detection of pancreatic cancer.

Zeh HJ, Winikoff S, Landsittel DP, Gorelik E, Marrangoni AM, Velikokhatnaya L, Winans MT, Lee K, Moser A, Bartlett D, Lotze MT, Siegfried JM, Whitcomb D, Papacristou G, Slivka A, Bigbee WL, Lokshin AE.

Cancer Biomark. 2005;1(6):259-69. Erratum in: Cancer Biomark. 2006;2(3-4):175. Papacristou, G [added].

PMID:
17192050
39.

Koopmans' theorem in the ROHF method: canonical form for the Hartree-Fock Hamiltonian.

Plakhutin BN, Gorelik EV, Breslavskaya NN.

J Chem Phys. 2006 Nov 28;125(20):204110.

PMID:
17144693
40.

A2A adenosine receptor protects tumors from antitumor T cells.

Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S, Sitkovsky M.

Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13132-7. Epub 2006 Aug 17.

41.

Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells.

Lokshin A, Raskovalova T, Huang X, Zacharia LC, Jackson EK, Gorelik E.

Cancer Res. 2006 Aug 1;66(15):7758-65.

42.

Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.

Heresco-Levy U, Javitt DC, Gelfin Y, Gorelik E, Bar M, Blanaru M, Kremer I.

J Affect Disord. 2006 Jul;93(1-3):239-43. Epub 2006 May 4.

PMID:
16677714
43.

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.

Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM, Gorelik E.

Gynecol Oncol. 2006 Aug;102(2):244-51. Epub 2006 Jan 24.

PMID:
16434085
44.

Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells.

Raskovalova T, Huang X, Sitkovsky M, Zacharia LC, Jackson EK, Gorelik E.

J Immunol. 2005 Oct 1;175(7):4383-91.

45.

Combined antiangiogenic and immune therapy of prostate cancer.

Huang X, Raskovalova T, Lokshin A, Krasinskas A, Devlin J, Watkins S, Wolf SF, Gorelik E.

Angiogenesis. 2005;8(1):13-23.

PMID:
16132614
46.

Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.

Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, Bigbee WL, Herberman RB, Lokshin AE.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):981-7.

47.

IL-12 receptor-mediated upregulation of FasL in human ovarian carcinoma cells.

Gorelik E, Edwards RP, Feng X, Marrangoni AM, Grandis JR, Drenning SD, Velikokhatnaya L, Kwon JA, Lokshin AE.

Int J Cancer. 2004 Nov 20;112(4):620-7.

48.

A novel apoptotic pathway as defined by lectin cellular initiation.

Gastman B, Wang K, Han J, Zhu ZY, Huang X, Wang GQ, Rabinowich H, Gorelik E.

Biochem Biophys Res Commun. 2004 Mar 26;316(1):263-71.

PMID:
15003540
49.

The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.

Li M, Huang X, Zhu Z, Zhao Q, Wong M, Gorelik E.

In Vivo. 2002 Nov-Dec;16(6):577-82.

PMID:
12494903
50.

Supplemental Content

Loading ...
Support Center